Apollomics, Inc. (APLM)

CIK 0001944885 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest FY-2025 —
FY-2024 —
FY-2023 —

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover Page
—
Statements
Consolidated Statements of Financial Position
—
Consolidated Statements of Profit Or Loss and Other Comprehensive Loss
—
Consolidated Statements of Loss and Other Comprehensive Loss
—
Consolidated Statements of Changes In Shareholders' (deficit) / Equity
—
Consolidated Statements of Changes In Shareholders' Equity / (deficit)
—
Consolidated Statements of Changes In Shareholders' Equity Deficit
—
Consolidated Statements of Changes In Shareholders' (deficit) / Equity (P)
—
Consolidated Statements of Changes In Shareholders' Equity / (deficit) (P)
—
Consolidated Statements of Changes In Shareholders' Equity Deficit (P)
—
Consolidated Statements of Cash Flows
—
Notes
Adoption of New and Amendments To Ifrss
—
Basis of Preparation of The Consolidated Financial Statements
—
Business Combination
—
Capital Risk Management
—
Cash and Cash Equivalents
—
Convertible Preferred Shares
—
Critical Accounting Judgment and Key Sources of Estimation Uncertainty
—
Cybersecurity Risk Management, Strategy, and Governance
—
Deferred Taxation
—
Deposits, Prepayments and Deferred Expenses
—
Dividends
—
Finance Costs
—
Financial Instruments
—
Financial Liabilities Arising From Unvested Restricted Shares
—
Foreign Exchange Gains and Losses
—
General Information
—
Income Tax Expenses
—
Insider Trading Policies and Procedures
—
Intangible Assets
—
Lease Liabilities
—
Litigation and Contingencies
—
Loss For The Year
—
Loss Per Share
—
Major Non-cash Transactions
—
Material Accounting Policies
—
New Standards, Amendments and Interpretations Issued By The Iasb
—
Other Gains and Losses
—
Other Income
—
Other Non-current Liabilities
—
Other Payables and Accruals
—
Plant and Equipment
—
Reconciliation of Liabilities Arising From Financing Activities
—
Related Party Disclosures
—
Restricted Net Assets
—
Retirement Benefits Plan
—
Revenue and Segment Information
—
Right-of-use Assets
—
Schedule I
—
Share Capital/treasury Shares
—
Share-based Payment Transactions
—
Short Term Bank Loans
—
Subsequent Events
—
Time Deposits With Original Maturity Over Three Months/cash and Cash Equivalents
—